Emerging roles of system antiporter and its inhibition in CNS disorders

References

• Abbott WA, Meister A. 1986. Intrahepatic transport and utilization of biliary glutathione and its metabolites. Proc Natl Acad Sci USA 83:1246–1250
   PubMed Web of Science ®Google Scholar
• Adair JC, Knoefel JE, Morgan N. 2001. Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease. Neurology 57:1515–1517
   PubMed Web of Science ®Google Scholar
• Alazne D, Álvarez A, Hilario E, Suarez-Merino B, Goñi-de-Cerio F. 2013. Central nervous system diseases and the role of the blood-brain barrier in their treatment. Neurosci Discov 1:1–8
   Google Scholar
• Allen JW, Shanker G, Aschner M. 2001. Methylmercury inhibits the in vitro uptake of the glutathione precursor, cystine, in astrocytes, but not in neurons. Brain Res 894:131–140
   PubMed Web of Science ®Google Scholar
• Amen SL, Piacentine LB, Ahmad ME, Li SJ, Mantsch JR, Risinger RC, Baker DA. 2011. Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans. Neuropsychopharmacology 36:871–878
   PubMed Web of Science ®Google Scholar
• Angulo MC, Kozlov AS, Charpak S, Audinat E. 2004. Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J Neurosci 24:6920–6927
   PubMed Web of Science ®Google Scholar
• Aoyama K, Matsumura N, Watabe M, Nakaki T. 2008. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. Eur J Neurosci 27:20–30
   PubMed Web of Science ®Google Scholar
• Asanuma M, Miyazaki I, Diaz-Corrales FJ, Kimoto N, Kikkawa Y, Takeshima M, et al. 2010. Neuroprotective effects of zonisamide target astrocyte. Ann Neurol 67:239–249
   PubMed Web of Science ®Google Scholar
• Asztely F, Erdemli G, Kullmann DM. 1997. Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron 18:281–293
   PubMed Web of Science ®Google Scholar
• Auer RN, Wieloch T, Olsson Y, Siesjo BK. 1984. The distribution of hypoglycemic brain damage. Acta Neuropathol 64:177–191
   PubMed Web of Science ®Google Scholar
• Augustin H, Grosjean Y, Chen K, Sheng Q, Featherstone D. 2007. Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo. J Neurosci 27:111–123
   PubMed Web of Science ®Google Scholar
• Azad Khan AK, Guthrie G, Johnston HH, Truelove SC, Williamson DH. 1983. Tissue and bacterial splitting of sulphasalazine. Clin Sci (Lond) 64:349–354.
   Google Scholar
• Baker DA, Madayag A, Kristiansen LV, Meador-Woodruff JH, Haroutunian V, Raju I. 2008. Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine. Neuropsychopharmacology 33:1760–1772
   PubMed Web of Science ®Google Scholar
• Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW. 2003. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6:743–749
   PubMed Web of Science ®Google Scholar
• Baker DA, Shen H, Kalivas PW. 2002a. Cystine/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration. Amino Acids 23:161–162
   PubMed Web of Science ®Google Scholar
• Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. 2002b. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci 22:9134–9141
   PubMed Web of Science ®Google Scholar
• Bakken IJ, White LR, Unsgard G, Aasly J, Sonnewald U. 1998. [U- 13C] glutamate metabolism in astrocytes during hypoglycemia and hypoxia. J Neurosci Res 51:636–645
   PubMed Web of Science ®Google Scholar
• Bannai S, Kitamura E. 1981. Role of proton dissociation in the transport of cystine and glutamate in human diploid fibroblasts in culture. J Biol Chem 256:5770–5772
   PubMed Web of Science ®Google Scholar
• Bannai S, Kitamura E. 1980. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem 255:2372–2376
   PubMed Web of Science ®Google Scholar
• Bannai S. 1984. Induction of cystine and glutamate transport activity in human fibroblasts by diethyl maleate and other electrophilic agents. J Biolog Chem 259:2435–2440
   PubMed Web of Science ®Google Scholar
• Bannai S, Takada A, Kasuga H, Tateishi N. 1986. Induction of cystine transport activity in isolated rat hepatocytes by sulfobromophthalein and other electrophilic agents. Hepatology 6(6):1361–1368
   PubMed Web of Science ®Google Scholar
• Barger SW. 2004. An unconventional hypothesis of oxidation in Alzheimer’s disease: intersections with excitotoxicity. Front Biosci 1(9):3286–3295
   Web of Science ®Google Scholar
• Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458–468
   PubMed Web of Science ®Google Scholar
• Begni B, Brighina L, Sirtori E, Fumagalli L, Andreoni S, Beretta S, et al. 2004. Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer’s disease. Free Radic Biol Med 37:892–901
   PubMed Web of Science ®Google Scholar
• Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, et al. 2008. N-Acetyl cysteine as a glutathione precursor for schizophrenia – a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 64:361–368
   PubMed Web of Science ®Google Scholar
• Berman AE, Chan WY, Brennan AM, Reyes RC, Adler BL, Suh SW, et al. 2011. N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse. Ann Neurol 69:509–520
   PubMed Web of Science ®Google Scholar
• Blandini F, Nappi G, Tassorelli C, Martignoni E. 2000. Functional changes in the basal ganglia circuitry in Parkinson’s disease. Prog Neurobiol 62:63–88
   PubMed Web of Science ®Google Scholar
• Bordji K, Becerril-Ortega J, Nicole O, Buisson A. 2010. Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-β production. J Neurosci 30:15927–15942
   Google Scholar
• Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, et al. 1997. Acute effects of cocaine on human brain activity and emotion. Neuron 19:591–611
   PubMed Web of Science ®Google Scholar
• Bridges CC, Kekuda R, Wang H, Prasad PD, Mehta P, Huang W, et al. 2001. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42(1):47–54
   PubMed Web of Science ®Google Scholar
• Bridges R, Lutgen V, Lobner D, Baker DA. 2012a. Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System ) to normal and pathological glutamatergic signaling. Pharmacol Rev 64(3):780–802
   PubMed Web of Science ®Google Scholar
• Bridges RJ, Natale NR, Patel SA. 2012b. System xc cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 165:20–34
   PubMed Web of Science ®Google Scholar
• Brown AS. 2011. The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23–58
   PubMed Web of Science ®Google Scholar
• Bulut M, Savas HA, Altindag A, Virit O, Dalkilic A. 2009. Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia. World J Biol Psychiatry 10:626–628
   PubMed Web of Science ®Google Scholar
• Burdo J, Dargusch R, Schubert D. 2006. Distribution of the cystine/glutamate antiporter system x-c in the brain, kidney, and duodenum. J Histochem Cytochem 54:549–557
   PubMed Web of Science ®Google Scholar
• Butterworth RF. 1999. Hypoglycemic encephalopathy. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uler MD, eds. Basic neurochemistry: Molecular, cellular and medical aspects. 6th ed. Philadelphia: Lippincott-Raven
   Google Scholar
• Carpenter VK, Drake LL, Aguirre SE, Price DP, Rodriguez SD, Hansen IA. 2012. SLC7 amino acid transporters of the yellow fever mosquito Aedes aegypti and their role in fat body TOR signaling and reproduction. J Insect Physiol 58(4):513–522
   PubMed Web of Science ®Google Scholar
• Chávez E, Castro-Sánchez L, Shibayama M, Tsutsumi V, Moreno MG, Muriel P. 2012. Sulfasalazine prevents the increase in TGF-β, COX-2, nuclear NFκB translocation and fibrosis in CCl4-induced liver cirrhosis in the rat. Hum Exp Toxicol 31(9):913–920
   PubMed Web of Science ®Google Scholar
• Cho RY, Konecky RO, Carter CS. 2006. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci USA 103:19878–19883
   PubMed Web of Science ®Google Scholar
• Cho Y, Bannai S. 1990. Uptake of glutamate and cystine in C-6 glioma cells and in cultured astrocytes. J Neurochem 55:2091–2097
   PubMed Web of Science ®Google Scholar
• Choi IY, Lee SP, Kim SG, Gruetter R. 2001. In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia. J Cereb Blood Flow Metab 21:653–663
   PubMed Web of Science ®Google Scholar
• Chua SE, Murray RM. 1996. The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. Ann Med 28:547–555
   PubMed Web of Science ®Google Scholar
• Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY, Sontheimer H. 2005. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 25(31):7101–7110
   PubMed Web of Science ®Google Scholar
• Clark J, Clore EL, Zheng K, Adame A, Masliah E, Simon DK. 2010. Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. PLoS One 5:12333
   PubMed Web of Science ®Google Scholar
• Conn PJ, Pin JP. 1997. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205–237
   PubMed Web of Science ®Google Scholar
• Correale J, Olsson T, Björk J, Smedegård G, Höjeberg B, Link H. 1991. Sulfasalazine aggravates experimental autoimmune encephalomyelitis and causes an increase in the number of autoreactive T cells. J Neuroimmunol 34:109–120
   PubMed Web of Science ®Google Scholar
• Coyle JT, Tsai G, Goff D. 2003. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann NY Acad Sci 1003:318–327
   PubMed Web of Science ®Google Scholar
• D’Ascenzo M, Fellin T, Terunuma M, Revilla-Sanchez R, Meaney DF, Auberson YP, et al. 2007. mGluR5 stimulates gliotransmission in the nucleus accumbens. Proc Natl Acad Sci USA 104:1995–2000
   PubMed Web of Science ®Google Scholar
• Diamond JS, Jahr CE. 2000. Synaptically released glutamate does not overwhelm transporters on hippocampal astrocytes during high-frequency stimulation. J Neurophysiol 83:2835–2843
   PubMed Web of Science ®Google Scholar
• De Bundel D, Schallier A, Loyens E, Fernando R, Miyashita H, Van Liefferinge J, Vermoesen K, Bannai S, Sato H, Michotte Y, Smolders I, Massie A. 2011. Loss of system does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J Neurosci 13:31(15):5792–5803
   Web of Science ®Google Scholar
• de Groot J, Sontheimer H. 2011. Glutamate and the biology of gliomas. Glia 59:1181–1189
   PubMed Web of Science ®Google Scholar
• Dennis SC, Clark JB. 1978. The regulation and glutamate metabolism by tricarboxylic acid-cycle activity in rat brain mitochondria. Biochem J 172:155–162
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Williams RO III. 2008. CNS disorders – current treatment options and the prospects for advanced therapies. Drug Dev Ind Pharm 34(11):1141–1167
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. 2014. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 20(3):2523
   Google Scholar
• Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, et al. 2000. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12:3721–3728
   PubMed Web of Science ®Google Scholar
• Domercq M, Sánchez-Gómez MV, Sherwin C, Etxebarria E, Fern R, Matute C. 2007. System and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 178(10):6549–6556
   PubMed Web of Science ®Google Scholar
• Dringen R, Pfeiffer B, Hamprecht B. 1999. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19:562–569
   PubMed Web of Science ®Google Scholar
• Erickson AM, Nevarea Z, Gipp JJ, Mulcahy RT. 2002. Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence. J Biolog Chem 277:30730–30737
   PubMed Web of Science ®Google Scholar
• Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H, et al. 2004. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 101:15506–15511
   PubMed Web of Science ®Google Scholar
• Featherstone DE. 2011. Glial solute carrier transporters in Drosophila and mice. Glia 59(9):1351–1363
   PubMed Web of Science ®Google Scholar
• Gasol E, Jiménez-Vidal M, Chillarón J, Zorzano A, Palacín M. 2004. Membrane topology of system light subunit reveals a re-entrant loop with substrate-restricted accessibility. J Biol Chem 279(30):31228–31236
   PubMed Web of Science ®Google Scholar
• Gemma C, Vila J, Bachstetter A, Bickford PC. Oxidative stress and the aging brain: From theory to prevention. In: Riddle DR, editor. Brain aging: Models, methods, and mechanisms. Boca Raton, FL: CRC Press; 2007. Chapter 15
   Google Scholar
• Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, et al. 1995. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27:119–137
   PubMed Web of Science ®Google Scholar
• Gochenauer GE, Robinson MB. 2001. Dibutyryl-cAMP (dbcAMP) upregulates astrocytic chloride-dependent L-[3H] transport and expression of both system subunits. J Neurochem 78:276–286
   PubMed Web of Science ®Google Scholar
• Goldberg MP, Choi DW. 1993. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 13:3510–3524
   PubMed Web of Science ®Google Scholar
• Gonzalez-Burgos G, Hashimoto T, Lewis DA. 2010. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep 12:335–344
   PubMed Web of Science ®Google Scholar
• Gonzalez-Burgos G, Lewis DA. 2008. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 34:944–961
   PubMed Web of Science ®Google Scholar
• Gout PW, Buckley AR, Simms CR, Bruchovsky N. 2001. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 15(10):1633–1640
   PubMed Web of Science ®Google Scholar
• Gout PW, Kang YJ, Buckley DJ, Bruchovsky N, Buckley AR. 1997. Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. Leukemia 11:1329–1337
   PubMed Web of Science ®Google Scholar
• Grosjean Y, Grillet M, Augustin H, Ferveur JF, Featherstone DE. 2008. A glial amino-acid transporter controls synapse strength and courtship in Drosophila. Nat Neurosci 11:54–61
   PubMed Web of Science ®Google Scholar
• Gupta DS, McCullumsmith RE, Beneyto M, Haroutunian V, Davis KL, Meador-Woodruff JH. 2005. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse 57:123–131
   PubMed Web of Science ®Google Scholar
• Halliwell B. 2006. Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Sekiyama N, Nakanishi S, Jane DE, Sunter DC, Birse EF, et al. 1994. Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes. J Neurosci 5(2):3370–3377
   Google Scholar
• Hosoya K, Tomi M, Ohtsuki S, Takanaga H, Saeki S, Kanai Y, et al. 2002. Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment. J Pharmacol Exp Ther 302:225–231
   PubMed Web of Science ®Google Scholar
• Ichord RN, Northington FJ, van Wylen D, Johnston MV, Kwon C, Traystman RJ. 1999. Brain O2 consumption and glutamate release during hypoglycemic coma in piglets are temperature sensitive. Am J Physiol Heart Circ Physiol 276:2053–2062
   Web of Science ®Google Scholar
• Ishii K, Muelhauser F, Liebl U, Picard M, Kühl S, Penke B, et al. 2000. Sub-acute NO generation induced by Alzheimer’s beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase. FASEB J 14:1485–1489
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13:76–86
   PubMed Web of Science ®Google Scholar
• Jabaudon D, Shimamoto K, Yasuda-Kamatani Y, Scanziani M, Gähwiler BH, Gerber U. 1999. Inhibition of uptake unmasks rapid extracellular turnover of gluamate of nonvesicular origin. Proc Natl Acad Sci USA 96:8733–8738
   PubMed Web of Science ®Google Scholar
• Jackman NA, Melchior SE, Hewett JA, Hewett SJ. 2012. Non-cell autonomous influence of the astrocyte system on hypoglycaemic neuronal cell death. ASN Neuro 4(1):e00074
   Google Scholar
• Kalivas PW. 2004. Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4(1):23–29
   PubMed Web of Science ®Google Scholar
• Kalivas PW. 2009. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561–572
   PubMed Web of Science ®Google Scholar
• Kalivas PW, Volkow N, Seamans J. 2005. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45:647–650
   PubMed Web of Science ®Google Scholar
• Kau KS, Madayag A, Mantsch JR, Grier MD, Abdul hameed O, Baker DA. 2008. Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking. Neuroscience 155:530–537
   PubMed Web of Science ®Google Scholar
• Kilberg MS, Pan Y-X, Chen H, Leung-Pineda V. 2005. Nutritional control of gene expression: how mammalian cells respond to amino acid limitation. Annu Rev Nutr 25:59–85
   PubMed Web of Science ®Google Scholar
• Kilberg MS, Hausingger D. 1992. Mammalian amino acid transport mechanism and control. Cambridge (MA): Cell Press
   Google Scholar
• Kim JY, Kanai Y, Chairoungdua A, Cha SH, Matsuo H, Kim DK, et al. 2001. Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim Biophys Acta 1512:335–344
   PubMed Web of Science ®Google Scholar
• Kimball SR. 1999. Eukaryotic initiation factor eIF2. Int J Biochem Cell Biol 31:25–29
   PubMed Web of Science ®Google Scholar
• Kleijn M, Proud CG. 2000. The activation of eukaryotic initiation factor (eIF)2B by growth factors in PC12 cells requires MEK/ERK signaling. FEBS Lett 476:262–265
   PubMed Web of Science ®Google Scholar
• Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S, et al. 2009. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry 65:841–845
   PubMed Web of Science ®Google Scholar
• Kodydková J, Vávrová L, Zeman M, Jirák R, Macásek J, Stanková B, et al. 2009. Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem 42:1368–1374
   PubMed Web of Science ®Google Scholar
• Koh JY, Yang LL, Cotman CW. 1990. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 533:315–320
   Google Scholar
• Kohr G, Eckardt S, Luddens H, Monyer H, Seeburg PH. 1994. NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12:1031–1040
   PubMed Web of Science ®Google Scholar
• Kranich O, Dringen R, Sandberg M, Hamprecht B. 1998. Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine. Glia 22:11–18
   PubMed Web of Science ®Google Scholar
• Kupchik YM, Moussawi K, Tang XC, Wang X, Kalivas BC, Kolokithas R, et al. 2012. The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry 71:978–986
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Furuie H, Inano A, Sunagawa A, Yamada S, Wu C, et al. 2012. Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Br J Pharmacol 166:1793–1803
   PubMed Web of Science ®Google Scholar
• Langan SJ, Deary IJ, Hepburn DA, Frier BM. 1991. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34:337–344
   PubMed Web of Science ®Google Scholar
• LaRowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, et al. 2007. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry 164:1115–1117
   PubMed Web of Science ®Google Scholar
• Lee JM, Johnson JA. 2004. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 37:139–143
   PubMedGoogle Scholar
• Lehre KP, Danbolt NC. 1998. The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J Neurosci 18:8751–8757
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Baxter P, Kassubek R, Albrecht P, Van Liefferinge J, Westhoff MA, et al. 2014. Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4. A pathway active in glioblastomas and epilepsy. Antioxid Redox Signal 20(18):2907–2922
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. 2013. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18(5):522–555
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Albrecht P, Tien ML, Henke N, Karumbayaram S, Kornblum HI, et al. 2009. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J Neurochem 111:332–343
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Maher P. 2009. Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J Biol Chem 284:1106–1115
   PubMed Web of Science ®Google Scholar
• Lim J, Li L, Kistler J, Donaldson PJ. 2007. Mapping of glutathione and its precursor amino acids reveals a role for GLYT2 in glycine uptake in the lens core. Invest Ophth Vis Sci 48:5142–5151
   PubMed Web of Science ®Google Scholar
• Lin X, Yang H, Zhang H, Zhou L, Guo Z. 2013. A novel transcription mechanism activated by ethanol: induction of Slc7a11 gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 (OCT-1). J Biol Chem 288:14815–14823
   PubMed Web of Science ®Google Scholar
• Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, Bankston LA. 2002. Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation. Trends Neurosci 25:474–480
   PubMed Web of Science ®Google Scholar
• Liu X, Resch J, Rush T, Lobner D. 2012. Functional upregulation of system by fibroblast growth factor-2. Neuropharmacology 62(2):901–906
   PubMed Web of Science ®Google Scholar
• Lo M, Wang YZ, Gout PW. 2008. The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 215:593–602
   PubMed Web of Science ®Google Scholar
• Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 1999. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122:2279–2295
   Google Scholar
• Lutgen V. 2012. The contribution of system to prefrontal cortical mediated behaviors associated with schizophrenia. Dissertations, Marquette University, Milwaukee, Wisconsin, USA
   Google Scholar
• Madayag A, Kau KS, Lobner D, Mantsch JR, Wisniewski S, Baker DA. 2010. Drug-induced plasticity contributing to heightened relapse susceptibility: neurochemical changes and augmented reinstatement in high-intake rats. J Neurosci 30:210–217
   PubMed Web of Science ®Google Scholar
• Madayag A, Lobner D, Kau KS, Mantsch JR, Abdulhameed O, Hearing M, et al. 2007. Repeated N-acetylcysteine administration alters plasticity dependent effects of cocaine. J Neurosci 27:13968–13976
   PubMed Web of Science ®Google Scholar
• Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ. 2007. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 31:389–394
   PubMed Web of Science ®Google Scholar
• Marino MJ, Conn PJ. 2002. Direct and indirect modulation of the N-methyl D-aspartate receptor. Curr Drug Targets CNS Neurol Disord 1:1–16
   PubMedGoogle Scholar
• Martin HL, Teismann P. 2009. Glutathione – a review on its role and significance in Parkinson’s disease. FASEB J 23(10):3263–3272
   PubMed Web of Science ®Google Scholar
• Massie A, Schallier A, Kim SW, Fernando R, Kobayashi S, Beck H, et al. 2011. Dopaminergic neurons of system x(c)−-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. FASEB J 25(4):1359–1369
   PubMed Web of Science ®Google Scholar
• Massie A, Schallier A, Mertens B, Vermoesen K, Bannai S, Sato H, et al. 2008. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. NeuroReport 19:1589–1592
   PubMed Web of Science ®Google Scholar
• Matti A, Mirzaei J, Rudolph J, Smith SA, Newell JL, Patel SA, et al. 2013. Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system transporter: initial homology model. Bioorg Med Chem Lett 23:5931–5935
   PubMed Web of Science ®Google Scholar
• Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. 1992. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376–389
   PubMed Web of Science ®Google Scholar
• Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R. 1997. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 94:8830–8835
   PubMed Web of Science ®Google Scholar
• McCarthy DJ, Alexander R, Smith MA, Pathak S, Kanes S, Lee CM, et al. 2012. Glutamate-based depression GBD. Med Hypotheses 78(5):675–681
   PubMed Web of Science ®Google Scholar
• McDonald DR, Brunden KR, Landreth GE. 1997. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci 17:2284–2294
   PubMed Web of Science ®Google Scholar
• Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, et al. 1995. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374:647–650
   PubMed Web of Science ®Google Scholar
• Mohan A, Pendyam S, Kalivas PW, Nair SS. 2011. Molecular diffusion model of neurotransmitter homeostasis around synapses supporting gradients. Neural Comput 23:984–1014
   PubMed Web of Science ®Google Scholar
• Monyer H, Choi DW. 1988. Morphinans attenuate cortical neuronal injury induced by glucose deprivation in vitro. Brain Res 446:144–148
   PubMed Web of Science ®Google Scholar
• Monyer H, Goldberg MP, Choi DW. 1989. Glucose deprivation neuronal injury in cortical culture. Brain Res 483:347–354
   PubMed Web of Science ®Google Scholar
• Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK. 2005. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci 25:6389–6393
   PubMed Web of Science ®Google Scholar
• Mosckovitz R, Yan N, Heimer E, Felix A, Tate SS, Udenfriend S. 1993. Characterization of the rat neutral and basic amino acid transporter utilizing anti-peptide antibodies. Proc Natl Acad Sci USA 90:4022–4026
   PubMed Web of Science ®Google Scholar
• Moussawi K, Zhou W, Shen H, Reichel CM, See RE, Carr DB, Kalivas PW. 2011. Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. Proc Natl Acad Sci USA 108:385–390
   PubMed Web of Science ®Google Scholar
• Murata M, Horiuchi E, Kanazawa I. 2001. Zonisamide has beneficial effects on Parkinson’s disease patients. Neurosci Res 41:397–399
   PubMed Web of Science ®Google Scholar
• Musazzi L, Treccani G, Popoli M. 2012. Glutamate hypothesis of depression and its consequences for antidepressant treatments. Expert Rev Neurother 12(10):1169–1172
   PubMed Web of Science ®Google Scholar
• Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K, et al. 1999. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 274(5):3009–3016
   PubMed Web of Science ®Google Scholar
• National Cancer Institute (NCI). 2015. Sorafenib and temsirolimus in treating patients with recurrent glioblastoma. Available from: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (USA). 2000- [accessed 2 April 2015]
   Google Scholar
• Newell JL, Keyari CM, McDaniel SW, Diaz PJ, Natale NR, Patel SA, Bridges RJ. 2014. Novel di-aryl-substituted isoxazoles act as noncompetitive inhibitors of the system Xc(-) cystine/glutamate exchanger. Neurochem Int 73:132–138
   PubMed Web of Science ®Google Scholar
• Niture SK, Jain AK, Jaiswal AK. 2009. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J Cell Sci 15(122):4452–4464
   Web of Science ®Google Scholar
• Noseworthy JH, O’Brien P, Erickson BJ, Lee D, Sneve D, Ebers GC, et al. 1998. The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis. Neurology 151:1342–1352
   Google Scholar
• Olivieri G, Baysang G, Meier F, Müller-Spahn F, Stähelin HB, Brockhaus M, Brack C. 2001. N-Acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation. J Neurochem 76:224–233
   PubMed Web of Science ®Google Scholar
• Ogunrinu TA, Sontheimer H. 2010. Hypoxia increases the dependence of glioma cells on glutathione. J Biolog Chem 285:37716–37724
   PubMed Web of Science ®Google Scholar
• Onyango IG, Bennett JP Jr, Tuttle JB. 2005. Endogenous oxidative stress in sporadic Alzheimer’s disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids. Neurobiol Dis 19:312–322
   PubMed Web of Science ®Google Scholar
• Pampliega O, Domercq M, Soria FN, Villoslada P, Rodríguez-Antigüedad A, Matute C. 2011. Increased expression of cystine/glutamate antiporter in multiple sclerosis. J Neuroinflammation 3(8):63
   Web of Science ®Google Scholar
• Park SW, Kim SH, Park KH, Kim SD, Kim JY, Baek SY, et al. 2004. Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson’s disease. Neurosci Lett 363:243–246
   PubMed Web of Science ®Google Scholar
• Pauly K, Fritz K, Furey A, Lobner D. 2011. Insulin-like growth factor 1 and transforming growth factor-β stimulate cystine/glutamate exchange activity in dental pulp cells. J Endod 37:943–947
   PubMed Web of Science ®Google Scholar
• Piani D, Fontana A. 1994. Involvement of the cystine transport system in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 152:3578–3585
   PubMed Web of Science ®Google Scholar
• Pierce RC, Bell K, Duffy P, Kalivas PW. 1996. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550–1560
   PubMed Web of Science ®Google Scholar
• Pow DV. 2001. Visualizing the activity of the cystine-glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate. Glia 34:27–38
   PubMed Web of Science ®Google Scholar
• Proud CG. 2005. eIF2 and the control of cell physiology. Semin Cell Dev Biol 16:3–12
   PubMed Web of Science ®Google Scholar
• Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M. 2006. System and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1–40. J Neurosci 26:3345–3356
   PubMed Web of Science ®Google Scholar
• Quevedo C, Alcázar A, Salinas M. 2000. Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal cells. J Biolog Chem 275:19192–19197
   PubMed Web of Science ®Google Scholar
• Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A. 2009. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 33:1178–1183
   PubMed Web of Science ®Google Scholar
• Ramos-Chávez LA, Rendón-López CRR, Zepeda A, Silva-Adaya D, Del Razo LM, Gonsebatt ME. 2015. Neurological effects of inorganic arsenic exposure: altered cysteine/glutamate transport, NMDA expression and spatial memory impairment. Front Cell Neurosci 9:21
   PubMed Web of Science ®Google Scholar
• Reichel CM, Moussawi K, Do PH, Kalivas PW, See RE. 2011. Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking. J Pharmacol Exp Ther 337:487–493
   PubMed Web of Science ®Google Scholar
• Reid MS, Berger SP. 1996. Evidence for sensitization of cocaine induced nucleus accumbens glutamate release. Neuroreport 7:1325–1329
   PubMed Web of Science ®Google Scholar
• Robe PA, Martin DH, Nguyen-Khac MT, Artesi M, Deprez M, Albert A, et al. 2009. Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer 9:372
   PubMed Web of Science ®Google Scholar
• Rothstein JD. 2002. Paving new pathways. Nat Med 8:938–940
   PubMed Web of Science ®Google Scholar
• Rowlands AG, Panniers R, Henshaw EC. 1988. The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J Biolog Chem 263:5526–5533
   PubMed Web of Science ®Google Scholar
• Rung JP, Carlsson A, Ryden Markinhuhta K, Carlsson ML. 2005. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:827–832
   PubMed Web of Science ®Google Scholar
• Ryan CM, Atchison J, Puczynski S, Puczynski M, Arslanian S, Becker D. 1990. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. J Pediatr 117:32–38
   PubMed Web of Science ®Google Scholar
• Sagara JI, Miura K, Bannai S. 1993. Maintenance of neuronal glutathione by glial cells. J Neurochem 61:1672–1676
   PubMed Web of Science ®Google Scholar
• Sanacora G, Treccani G, Popoli M. 2012. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62(1):63–77
   PubMed Web of Science ®Google Scholar
• Sandberg M, Butcher SP, Hagberg H. 1986. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem 47:178–184
   PubMed Web of Science ®Google Scholar
• Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, et al. 2002. Electrophilic response element-mediated induction of the cystine/gluamate exchange transporter gene expression. J Biol Chem 274:44765–44771
   Web of Science ®Google Scholar
• Sato H, Nomura S, Maebara K, Sato K, Tamba M, Bannai S. 2004. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem Biophys Res Commun 325(1):109–116
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Okuno S, Sato K, Keino-Masu K, Masu M, Bannai S. 2002. Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain. J Neurosci 22(18):8028–8033
   PubMed Web of Science ®Google Scholar
• Sato H, Kuriyama-Matsumura K, Hashimoto T, Sasaki H, Wang H, Ishii T, et al. 2001. Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages. J Biolog Chem 276:10407–10412
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Kuriyama-Matsumura K, Okuno S, Bannai S. 2000. Molecular cloning and expression of human xCT, the light chain of amino acid transport system . Antioxid Redox Signal 2:665–671
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Ishii T, Bannai S. 1999. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274(17):11455–11458
   PubMed Web of Science ®Google Scholar
• Savaskan NE, Heckel A, Hahnen E, Engelhorn T, Doerfler A, Ganslandt O, et al. 2008. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med 14(6):629–632
   PubMed Web of Science ®Google Scholar
• Savtchenko LP, Rusakov DA. 2004. Glutamate escape from a tortuous synaptic cleft of the hippocampal mossy fibre synapse. Neurochem Int 45:479–484
   PubMed Web of Science ®Google Scholar
• Schallier A, Smolders I, Van Dam D, Loyens E, De Deyn PP, Michotte A, et al. 2011. Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer’s disease. J Alzheimers Dis 24(2):287–300
   PubMed Web of Science ®Google Scholar
• Schulz JB, Lindenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904–4911
   PubMedGoogle Scholar
• Seib TM, Patel SA, Bridges RJ. 2011. Regulation of the system x(C)- cystine/glutamate exchanger by intracellular glutathione levels in rat astrocyte primary cultures. Glia 59(10):1387–1401
   PubMed Web of Science ®Google Scholar
• Shanker G, Aschner M. 2001. Identification and characterization of uptake systems for cystine and cysteine in cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport. J Neurosci Res 66:998–1002
   PubMed Web of Science ®Google Scholar
• Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. 2006. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26(41):10514–10523
   PubMed Web of Science ®Google Scholar
• Shukla K, Thomas AG, Ferraris DV, Hin N, Sattler R, Alt J, et al. 2011. Inhibition of transporter-mediated cystine uptake by sulfasalazine analogs. Bioorg Med Chem Lett 21(20):6184–6187
   PubMed Web of Science ®Google Scholar
• Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. 1998. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 95(1):316–321
   PubMed Web of Science ®Google Scholar
• Silverstein FS, Simpson J, Gordon KE. 1990. Hypoglycemia alters striatal amino acid efflux in perinatal rats: an in vivo microdialysis study. Ann Neurol 28:516–521
   PubMed Web of Science ®Google Scholar
• Sims B, Clarke M, Francillion L, Kindred E, Hopkins ES, Sontheimer H. 2012. Hypoxic preconditioning involves system Xc- regulation in mouse neural stem cells. Stem Cell Res 8:285–291
   PubMed Web of Science ®Google Scholar
• Singer E, Judkins J, Salomonis N, Matlaf L, Soteropoulos P, McAllister S, Soroceanu L. 2015. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Cell Death Dis 6:e1601–e1611
   PubMed Web of Science ®Google Scholar
• Stover JF, Pleines UE, Morganti-Kossmann MC, Kossmann T, Lowitzsch K, Kempski OS. 1997. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 27:1038–1043
   PubMed Web of Science ®Google Scholar
• Suh SW, Hamby AM, Swanson RA. 2007. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 55:1280–1286
   PubMed Web of Science ®Google Scholar
• Takaki M, Ueda Y, Doi T, Nagatomo K, Murashima YL, Kannan H. 2008. Molecular regulation of antioxidant ability in the hippocampus of EL mice. Brain Res 1228:1–5
   PubMed Web of Science ®Google Scholar
• Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. 2001. Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010–1015
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Wada K, Toyooka T, Shinomiya N, Shimazaki H, Nakanishi K, et al. 2013. Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. Neurosurgery 72(1):33–41
   PubMed Web of Science ®Google Scholar
• Tanel A, Averill-Bates DA. 2007. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J Pharmacol Exp Ther 321:73–83
   PubMed Web of Science ®Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278–285
   PubMed Web of Science ®Google Scholar
• Uys JD, LaLumiere RT. 2008. Glutamate: the new frontier in pharmacotherapy for cocaine addiction. CNS Neurol Disord Drug Targets 7:482–491
   PubMed Web of Science ®Google Scholar
• Venugopal R, Jaiswal AK. 1996. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 93:14960–14965
   PubMed Web of Science ®Google Scholar
• Verma A, Moghaddam B. 1996. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16:373–379
   PubMed Web of Science ®Google Scholar
• Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. 2004. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 447(5):532–542
   PubMed Web of Science ®Google Scholar
• Wadiche JI, Arriza JL, Amara SG, Kavanaugh MP. 1995. Kinetics of a human glutamate transporter. Neuron 14:1019–1027
   PubMed Web of Science ®Google Scholar
• Wagner CA, Lang F, Bröer S. 2001. Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 1(4):C1077–1093
   Google Scholar
• Wang XF, Cynader MS. 2000. Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem 74:1434–1442
   PubMed Web of Science ®Google Scholar
• Waniewski RA, Martin DL. 1984. Characterization of L-glutamic acid transport by glioma cells in culture: evidence for sodium-independent, chloride-dependent high affinity influx. J Neurosci 4(9):2237–2246
   PubMed Web of Science ®Google Scholar
• Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669
   PubMed Web of Science ®Google Scholar
• Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O’Hare E, et al. 1998. Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 18:2161–2173
   PubMed Web of Science ®Google Scholar
• Wells RG, Hediger MA. 1992. Cloning of a rat kidney cDNA that stimulates dibasic and neutral amino acid transport and has sequence similarity to glucosidases. Proc Natl Acad Sci USA 89:5596–5600
   PubMed Web of Science ®Google Scholar
• Wells RG, Lee WS, Kanai Y, Leiden JM, Hediger MA. 1992. The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes. J Biol Chem 267:15285–15288
   PubMed Web of Science ®Google Scholar
• Welsh GI, Miller CM, Loughlin AJ, Price NT, Proud CG. 1998. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett 421:125–130
   PubMed Web of Science ®Google Scholar
• Welsh GI, Proud CG. 1993. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294:625–629
   PubMed Web of Science ®Google Scholar
• Wolf ME. 2010. The Bermuda Triangle of cocaine-induced neuroadaptations. Trends Neurosci 33:391–398
   PubMed Web of Science ®Google Scholar
• Xi ZX, Ramamoorthy S, Baker DA, Shen H, Samuvel DJ, Kalivas PW. 2002. Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine. J Pharmacol Exp Ther 303:608–615
   PubMed Web of Science ®Google Scholar
• Xi ZX, Shen H, Baker DA, Kalivas PW. 2003. Inhibition of non-vesicular glutamate release by group III metabotropic glutamate receptors in the nucleus accumbens. J Neurochem 87:1204–1212
   PubMed Web of Science ®Google Scholar
• Xu C, Yogaratnam J, Lua R, Naik S, Khoo CL, Pillai SS, Sim K. 2011. Persistent, severe hypoglycemia-induced organic brain syndrome with neurological sequelae: a case report. Gen Hosp Psychiatry 33:9–11
   Web of Science ®Google Scholar
• Ye ZC, Rothstein JD, Sontheimer H. 1999. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci 19:10767–10777
   PubMed Web of Science ®Google Scholar
• Ye ZC, Sontheimer H. 1999. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383–4391
   PubMed Web of Science ®Google Scholar
• Yang Y, Yee D. 2014. IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule . Cancer Res 74(8):2295–2305
   PubMed Web of Science ®Google Scholar
• Zechel S, Werner S, Unsicker K, von Bohlen und Halbach O, . 2010. Expression and functions of fibroblast growth factor 2 (FGF-2) in hippocampal formation. Neuroscientist 16:357–373
   PubMed Web of Science ®Google Scholar
• Zhang P, McGrath BC, Reinert J, Olsen DS, Lei L, Gill S, et al. 2002. The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice. Mol Cell Biol 22:6681–6688
   PubMed Web of Science ®Google Scholar
• Zheng K, Scimemi A, Rusakov DA. 2008. Receptor actions of synaptically released glutamate: the role of transporters on the scale from nanometers to microns. Biophys J 95:4584–4596
   PubMed Web of Science ®Google Scholar